Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb:5:1-22.
doi: 10.1200/JGO.18.00213.

Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline

Gilberto Lopes  1 , Mariana C Stern  2 , Sarah Temin  3 , Ala I Sharara  4 , Andres Cervantes  5 , Ainhoa Costas-Chavarri  6 , Rena Engineer  7 , Chisato Hamashima  8 , Gwo Fuang Ho  9 , Fidel David Huitzil  10 , Mona Malekzadeh Moghani  11 , Govind Nandakumar  12 , Manish A Shah  13 , Catherine Teh  14 , Sara E Vázquez Manjarrez  10 , Azmina Verjee  15 , Rhonda Yantiss  13 , Marcia Cruz Correa  16
Affiliations

Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline

Gilberto Lopes et al. J Glob Oncol. 2019 Feb.

Erratum in

Abstract

Purpose: To provide resource-stratified, evidence-based recommendations on the early detection of colorectal cancer in four tiers to clinicians, patients, and caregivers.

Methods: American Society of Clinical Oncology convened a multidisciplinary, multinational panel of medical oncology, surgical oncology, surgery, gastroenterology, health technology assessment, cancer epidemiology, pathology, radiology, radiation oncology, and patient advocacy experts. The Expert Panel reviewed existing guidelines and conducted a modified ADAPTE process and a formal consensus-based process with additional experts (Consensus Ratings Group) for two round(s) of formal ratings.

Results: Existing sets of guidelines from eight guideline developers were identified and reviewed; adapted recommendations form the evidence base. These guidelines, along with cost-effectiveness analyses, provided evidence to inform the formal consensus process, which resulted in agreement of 75% or more.

Conclusion: In nonmaximal settings, for people who are asymptomatic, are ages 50 to 75 years, have no family history of colorectal cancer, are at average risk, and are in settings with high incidences of colorectal cancer, the following screening options are recommended: guaiac fecal occult blood test and fecal immunochemical testing (basic), flexible sigmoidoscopy (add option in limited), and colonoscopy (add option in enhanced). Optimal reflex testing strategy for persons with positive screens is as follows: endoscopy; if not available, barium enema (basic or limited). Management of polyps in enhanced is as follows: colonoscopy, polypectomy; if not suitable, then surgical resection. For workup and diagnosis of people with symptoms, physical exam with digital rectal examination, double contrast barium enema (only in basic and limited); colonoscopy; flexible sigmoidoscopy with biopsy (if contraindication to latter) or computed tomography colonography if contraindications to two endoscopies (enhanced only).

PubMed Disclaimer

References

    1. Stoffel EM, Mangu PB, Gruber SB, et al. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol. 2015;33:209–217. - PMC - PubMed
    1. International Agency for Research on Cancer http://gco.iarc.fr/today/fact-sheets-cancers?cancer=6&type=0&sex=0 Cancer fact sheets: Colorectal cancer.
    1. American Cancer Society . Global cancer facts & figures (ed 3) Atlanta, GA: American Cancer Society; 2015.
    1. Anderson BO, Shyyan R, Eniu A, et al. Breast cancer in limited-resource countries: An overview of the Breast Health Global Initiative 2005 guidelines. Breast J. 2006;12:S3–S15. - PubMed
    1. Horton S, Gavreau CL. Cancer in low- and middle-income countries: An economic overview. In: Gelband H, Jha P, Sankaranarayanan R, , (eds), editors. Cancer: Disease Control Priorities. ed 3. Washington, DC: 2015.